Grid-Added Value to Address Malaria

Through this paper, we call for a distributed, Internet- based collaboration to address one of the worst plagues of our present world, malaria. The spirit is a nonproprietary peer-production of information-embedding goods. And we propose to use the grid technology to enable such a worldwide "open-source" like collaboration. The first step toward this vision has been achieved during the summer 2005 on the enabling grids for E-scienceE (EGEE) grid infrastructure where 42 million ligands were docked for a total amount of 80 CPU years in 6 weeks in the quest for new drugs. The impact of this first deployment has significantly raised the interest of the research community so that several laboratories all around the world expressed interest to propose targets for a second large-scale deployment against malaria.

[1]  K. Buetow.  Cyberinfrastructure: Empowering a "Third Way" in Biomedical Research , 2005, Science.

[2]  S. Hay,et al.  Satellite imagery in the study and forecast of malaria , 2002, Nature.

[3]  International Human Genome Sequencing Consortium.  Initial sequencing and analysis of the human genome , 2001, Nature.

[4]  C. Curtis,et al.  The Case for Deemphasizing Genomics in Malaria Control , 2000, Science.

[5]  R E Cachau,et al.  Structure and inhibition of plasmepsin II, a hemoglobin-degrading enzyme from Plasmodium falciparum. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[6]  Li Li,et al.  PlasmoDB: the Plasmodium genome resource. A database integrating experimental and computational data , 2003, Nucleic Acids Res..

[7]  N. Jacq,et al.  Grid-Enabled High-Throughput In Silico Screening Against Influenza A Neuraminidase , 2006, IEEE Transactions on NanoBioscience.

[8]  A. M. SILVA,et al.  Structure and inhibition of plasmepsin II , a hemoglobin-degrading enzyme from Plasmodiumfalciparum ( malaria / drug design / crystallography / aspartic protease / cathepsin D ) , .

[9]  N. Jacq,et al.  Towards grid-enabled telemedicine in Africa , 2006 .

[10]  Marco Roos,et al.  The promise of a virtual lab in drug discovery. , 2006, Drug discovery today.

[11]  Rajkumar Buyya,et al.  The Australian BioGrid Portal: Empowering the Molecular Docking Research Community , 2005 .

[12]  Kiyoko F. Aoki-Kinoshita,et al.  From genomics to chemical genomics: new developments in KEGG , 2005, Nucleic Acids Res..

[13]  Vincent Breton,et al.  In Silico Docking on Grid Infrastructures , 2006 .

[14]  J. Schug,et al.  The Plasmodium genome database , 2002, Nature.

[15]  Yongyuth Yuthavong,et al.  Crystal structure of dihydrofolate reductase from Plasmodium vivax: pyrimethamine displacement linked with mutation-induced resistance. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[16]  D. Mccormick.  Sequence the Human Genome , 1986, Bio/Technology.

[17]  Johan Montagnat,et al.  Grid-enabled Virtual Screening Against Malaria , 2006, Journal of Grid Computing.

[18]  Patrick A. Curmi,et al.  Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain , 2004, Nature.

[19]  R. Coppel,et al.  Bioinformatics and the malaria genome: facilitating access and exploitation of sequence information. , 2001, Molecular and biochemical parasitology.

[20]  Access Series,et al.  Communication for IT , 2006 .

[21]  David Abramson,et al.  High performance parametric modeling with Nimrod/G: killer application for the global grid? , 2000, Proceedings 14th International Parallel and Distributed Processing Symposium. IPDPS 2000.

[22]  Yongyuth Yuthavong,et al.  Insights into antifolate resistance from malarial DHFR-TS structures , 2003, Nature Structural Biology.

[23]  Jonathan E. Allen,et al.  Genome sequence of the human malaria parasite Plasmodium falciparum , 2002, Nature.

[24]  Ian Foster,et al.  Grid technologies empowering drug discovery. , 2002, Drug discovery today.

[25]  G Losonsky,et al.  Long-term persistence of sterile immunity in a volunteer immunized with X-irradiated Plasmodium falciparum sporozoites. , 1993, The Journal of infectious diseases.

[26]  M. Perbandt,et al.  Native and Inhibited Structure of a Mu class-related Glutathione S-transferase from Plasmodium falciparum* , 2004, Journal of Biological Chemistry.

[27]  David S. Goodsell,et al.  Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function , 1998, J. Comput. Chem..

[28]  Torsten Schwede,et al.  The SwissBioGrid Project : objectives, preliminary results and lessons learned , 2006 .

[29]  Mark James,et al.  Biomedical Informatics Research Network: Building a National Collaboratory to Hasten the Derivation of New Understanding and Treatment of Disease , 2005, HealthGrid.

[30]  Tom L. Blundell,et al.  Keynote review: Structural biology and drug discovery , 2005 .

[31]  Paul D Lyne,et al.  Structure-based virtual screening: an overview. , 2002, Drug discovery today.

[32]  J. An,et al.  Structure-based virtual screening of chemical libraries for drug discovery. , 2006, Current opinion in chemical biology.

[33]  B Irthum,et al.  Empowering Humanitarian Medical Development Using Grid Technology , 2005, Methods of Information in Medicine.

[34]  David Abramson,et al.  The Virtual Laboratory: a toolset to enable distributed molecular modelling for drug design on the World‐Wide Grid , 2003, Concurr. Comput. Pract. Exp..

[35]  David Abramson,et al.  Nimrod/G: an architecture for a resource management and scheduling system in a global computational grid , 2000, Proceedings Fourth International Conference/Exhibition on High Performance Computing in the Asia-Pacific Region.

[36]  Jun Zhang,et al.  Drug Discovery Grid , 2005 .

[37]  Rumen Andonov,et al.  Le projet GénoGRID : une grille expérimentale pour la génomique , 2002 .

[38]  Jochen Wiesner,et al.  New antimalarial drugs. , 2003, Angewandte Chemie.

[39]  David A. Fidock,et al.  Antimalarial drug discovery: efficacy models for compound screening , 2004, Nature Reviews Drug Discovery.

[40]  David J. Garcia Aristegui,et al.  GROCK: high-throughput docking using LCG grid tools , 2005, The 6th IEEE/ACM International Workshop on Grid Computing, 2005..

[41]  David S. Goodsell,et al.  Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function , 1998 .

[42]  D. Carucci,et al.  Advances in malaria genomics since MIM Arusha, 2002. , 2005, Acta tropica.

[43]  T. Blundell,et al.  Structural biology and drug discovery. , 2005, Drug discovery today.

[44]  D. Goldberg,et al.  Aspartic proteases of Plasmodium falciparum and other parasitic protozoa as drug targets. , 2001, Trends in parasitology.

[45]  Scott Gustafson,et al.  caCORE: A common infrastructure for cancer informatics , 2003, Bioinform..

[46]  Carole A. Goble,et al.  myGrid: personalised bioinformatics on the information grid , 2003, ISMB.

[47]  Jian Wang,et al.  The Genome Sequence of the Malaria Mosquito Anopheles gambiae , 2002, Science.

[48]  Thomas Lengauer,et al.  A fast flexible docking method using an incremental construction algorithm. , 1996, Journal of molecular biology.

[49]  Martin Hofmann-Apitius,et al.  Integration and mining of malaria molecular, functional and pharmacological data: how far are we from a chemogenomic knowledge space? , 2006, Malaria Journal.

[50]  T. N. Bhat,et al.  The Protein Data Bank , 2000, Nucleic Acids Res..

[51]  D. Sullivan,et al.  Hemoglobin metabolism in the malaria parasite Plasmodium falciparum. , 1997, Annual review of microbiology.

[52]  J M Blaney,et al.  A geometric approach to macromolecule-ligand interactions. , 1982, Journal of molecular biology.

[53]  Fabrizio Gagliardi,et al.  Building an infrastructure for scientific Grid computing: status and goals of the EGEE project , 2005, Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences.

[54]  Brian K. Shoichet,et al.  ZINC - A Free Database of Commercially Available Compounds for Virtual Screening , 2005, J. Chem. Inf. Model..

[55]  Solomon Nwaka,et al.  Science & society: Virtual drug discovery and development for neglected diseases through public–private partnerships , 2003, Nature Reviews Drug Discovery.